MiR-300 regulate the malignancy of breast cancer by targeting p53

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 5, 2015, Pages 6957-6966

  Xu, Xiao Heng ^a   Li, Da Wei ^b   Feng, Hui ^a   Chen, Hong Mei ^a   Song, Yan Qiu ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b BEIHUA UNIVERSITY   (China)

Author keywords

Breast cancer; MCF 7; MiR 300; P53; Target therapy

Indexed keywords

MICRORNA; MICRORNA 300; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CARCINOGENESIS; CELL CYCLE; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; MALE; MCF 7 CELL LINE; MOUSE; MTT ASSAY; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING;

EID: 84937053439     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. [1] Anastasov N, Höfig I, Vasconcellos IG, Rappl K, Braselmann H, Ludyga N, Auer G, Aubele M, Atkinson MJ. Radiation resistance due to high expression of miR-21 and G2/M checkpoint arrest inbreast cancercells. Radiat Oncol 2012; 7: 206.
2. [2] Dib L, Carbone A. CLAG: an unsupervised non hierarchical clustering algorithm handling biological data. BMC Bioinformatics 2012; 13: 194.
3. [3] Gerson KD, Maddula VS, Seligmann BE, Shearstone JR, Khan A, Mercurio AM. Effects of β4 integrin expression onmicroRNApatterns inbreast cancer. Biol Open 2012; 1: 658-66.
4. [4] Siragam V, Rutnam ZJ, Yang W, Fang L, Luo L, Yang X, Li M, Deng Z, Qian J, Peng C, Yang BB. MicroRNAmiR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11. Oncotarget 2012; 3: 1370-85.
5. [5] Liu SX, Zhang YJ, Guo HF, Hao J, Liu QJ, Liu JR, Guo JW, Liu JH, Zuo LF. The regulatory effect of the p38 signaling pathway on valdecoxib-induced apoptosis of the Eca109 cell line. Oncol Rep 2009; 22: 313-9.
6. [6] Kopp F, Oak PS, Wagner E, Roidl A. miR-200c sensitizesbreast cancercells to doxorubicin treatment by decreasing TrkB and Bmi1 expression. PLoS One 2012; 7: e50469.
7. [7] Steinfeld I, Navon R, Ach R, Yakhini Z. miRNA target enrichment analysis reveals directly active miRNAs in health and disease. Nucleic Acids Res 2013; 41: e45.
8. [8] Tang J, Ahmad A, Sarkar FH. The role ofmicroRNAsinbreast cancermigration, invasion and metastasis. Int J Mol Sci 2012; 13: 13414-37.
9. [9] Guo L, Zhao Y, Yang S, Cai M, Wu Q, Chen F. Genome-wide screen for aberrantly expressed miRNAs reveals miRNA profile signature inbreast cancer. Mol Biol Rep 2013; 40: 2175-86.
10. [10] Jiang Y, Qin Z, Hu Z, Guan X, Wang Y, He Y, Xue J, Liu X, Chen J, Dai J, Jin G, Ma H, Wang S, Shen H. Genetic variation in a hsa-let-7 binding site in RAD52 is associated withbreast cancersusceptibility. Carcinogenesis 2013; 34: 689-93.
11. [11] Howe EN, Cochrane DR, Cittelly DM, Richer JK. miR-200c targets a NF-κB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negativebreast cancer. PLoS One 2012; 7: e49987.
12. [12] Wennemers M, Bussink J, van den Beucken T, Sweep FC, Span PN. Regulation of TRIB3 mRNA and protein inbreast cancer. PLoS One 2012; 7: e49439.
13. [13] Liang Z, Ahn J, Guo D, Votaw JR, Shim H. MicroRNA-302 replacement therapy sensitizesbreast cancercells to ionizing radiation. Pharm Res 2013; 30: 1008-16.
14. [14] Endo Y, Toyama T, Takahashi S, Yoshimoto N, Iwasa M, Asano T, Fujii Y, Yamashita H. miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positivebreast cancer. Endocr Relat Cancer 2013; 20: 91-102.
15. [15] Li P, Sheng C, Huang L, Zhang H, Huang L, Cheng Z, Zhu Q. MiR-183/-96/-182 cluster is up-regulated in mostbreastcancers and increases cell proliferation and migration. Breast Cancer Res 2014; 16: 473.
16. [16] Sun EH, Zhou Q, Liu KS, Wei W, Wang CM, Liu XF, Lu C, Ma DY. Screening miRNAs related to different subtypes ofbreast cancerwith miRNAs microarray. Eur Rev Med Pharmacol Sci 2014; 18: 2783-8.
17. [17] Cai ZK, Chen Q, Chen YB, Gu M, Zheng DC, Zhou J, Wang Z. microRNA-155 promotes the proliferation of prostate cancercells by targeting annexin7. Mol Med Rep 2015; 11: 533-8.
18. [18] Bockhorn J, Prat A, Chang YF, Liu X, Huang S, Shang M, Nwachukwu C, Gomez-Vega M, Harrell JC, Olopade OI, Perou CM, Liu H. Differentiation and loss of malignant character of spontaneous pulmonary metastases in patient-derived breast cancer models. Cancer Res 2014; 74: 7406-17.
19. [19] Erturk E, Cecener G, Polatkan V, Gokgoz S, Egeli U, Tunca B, Tezcan G, Demirdogen E, Ak S, Tasdelen I. Evaluation of Genetic Variations in miRNA-Binding Sites of BRCA1 and BRCA2 Genes as Risk Factors for the Development of Early-Onset and/or FamilialBreast Cancer. Asian Pac J Cancer Prev 2014; 15: 8319-24.
20. [20] Pan F, Mao H, Deng L, Li G, Geng P. Prognostic and clinicopathological significance ofmicroRNA-21 overexpression inbreast cancer: a meta-analysis. Int J Clin Exp Pathol 2014; 7: 5622-33.
21. [21] Yao Y, Li J, Wang L. Large Intervening Non-Coding RNA HOTAIR Is an Indicator of Poor Prognosis and a Therapeutic Target in Human Cancers. Int J Mol Sci 2014; 15: 18985-18999.
22. [22] Wang L, Wang Q, Li HL, Han LY. Expression of MiR200a, miR93, metastasis-related gene RECK and MMP2/MMP9 in human cervical carcinoma--relationship with prognosis. Asian Pac J Cancer Prev 2013; 14: 2113-8.
23. [23] Li JY, Zhang Y, Zhang WH, Jia S, Kang Y, Tian R. Effects of differential distribution of microvessel density, possibly regulated by miR-374a, onbreast cancerprognosis. Asian Pac J Cancer Prev 2013; 14: 1715-20.
24. [24] Vannier C, Mock K, Brabletz T, Driever W. Zeb1 regulates E-cadherin and Epcam (epithelial cell adhesion molecule) expression to control cell behavior in early zebrafish development. J Biol Chem 2013; 288: 18643-59.
25. [25] Danza K, De Summa S, Pinto R, Pilato B, Palumbo O, Merla G, Simone G, Tommasi S. MiR-578 and miR-573 as potential players in BRCA-relatedbreast cancerangiogenesis. On-cotarget 2015; 6: 471-83.
26. [26] Bao B, Azmi AS, Ali S, Zaiem F, Sarkar FH. Metformin may function as anti-canceragent via targetingcancerstem cells: the potential biological significance of tumor-associated miRNAs inbreastand pancreatic cancers. Ann Transl Med 2014; 2: 59.
27. [27] Huang X, Lv W, Zhang JH, Lu DL. miR-96 functions as a tumor suppressor gene by targeting NUAK1 in pancreaticcancer. Int J Mol Med 2014; 34: 1599-605.
28. [28] Finlay-Schultz J, Cittelly DM, Hendricks P, Patel P, Kabos P, Jacobsen BM, Richer JK, Sartorius CA. Progesterone downregulation of miR-141 contributes to expansion of stem-likebreast cancercells through maintenance of progesterone receptor and Stat5a. Cancer Res 2014; [Epub ahead of print].
29. [29] Mathsyaraja H, Thies K, Taffany DA, Deighan C, Liu T, Yu L, Fernandez SA, Shapiro C, Otero J, Timmers C, Lustberg MB, Chalmers J, Leone G, Ostrowski MC. CSF1-ETS2-inducedmicroRNAin myeloid cells promote metastatic tumor growth. Cancer Res 2014; [Epub ahead of print].
30. [30] Hu J, Xu J, Wu Y, Chen Q, Zheng W, Lu X, Zhou C, Jiao D. Identification ofmicroRNA-93 as a functional dysregulated miRNA in triple-negativebreast cancer. Tumour Biol 2014; 36: 251-8.
31. [31] Tan X, Peng J, Fu Y, An S, Rezaei K, Tabbara S, Teal CB, Man YG, Brem RF, Fu SW. miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple negativebreast cancer. Breast Cancer Res 2014; 16: 435.
32. [32] Mishra S, Lin CL, Huang TH, Bouamar H, Sun LZ. MicroRNA-21 inhibits p57Kip2 expression in prostatecancer. Mol Cancer 2014; 13: 212.
33. [33] Chang S, Sharan SK. The role of epigenetic transcriptional regulation in BRCA1-mediated tumor suppression. Transcription 2013; 4: 24-8.
34. [34] Yang ZX, Lu CY, Yang YL, Dou KF, Tao KS. MicroRNA-125b expression in gastric adenocarcinoma and its effect on the proliferation of gastriccancercells. Mol Med Rep 2013; 7: 229-32.
35. [35] Biagioni F, Bossel Ben-Moshe N, Fontemaggi G, Canu V, Mori F, Antoniani B, Di Benedetto A, Santoro R, Germoni S, De Angelis F, Cambria A, Avraham R, Grasso G, Strano S, Muti P, Mottolese M, Yarden Y, Domany E, Blandino G. miR-10b, a master inhibitor of the cell cycle, is down-regulated in humanbreasttumours. EMBO Mol Med 2012; 4: 1214-29.